Hyloris Pharmaceuticals SA
EBR:HYL.BR
4.8 (EUR) • At close November 8, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) EUR.
| 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 1.527 | 1.527 | 0.58 | 0.58 | 0.677 | 0.677 | 1.033 | 0.516 | 2.258 | 1.129 | 0.838 | 0.419 | 0.047 | 0.047 | 0.019 | 0.063 | 0.008 | 0.008 | 0.035 | 0.04 |
| Kosten van de omzet
| 0.024 | 0.024 | 0.023 | 0.023 | 0.017 | 0.017 | 0.061 | 0.031 | 0.109 | 0.033 | 0.042 | 0.021 | 0.018 | 0.018 | 0.089 | 0.02 | 0.015 | 0.015 | 0.014 | 0.023 |
| Brutowinst
| 1.504 | 1.504 | 0.557 | 0.557 | 0.661 | 0.661 | 0.972 | 0.486 | 2.149 | 1.097 | 0.796 | 0.398 | 0.029 | 0.029 | -0.07 | 0.043 | -0.007 | -0.007 | 0.021 | 0.017 |
| Brutowinstmarge
| 0.985 | 0.985 | 0.96 | 0.96 | 0.976 | 0.976 | 0.941 | 0.941 | 0.952 | 0.971 | 0.95 | 0.95 | 0.613 | 0.613 | -3.684 | 0.683 | -0.813 | -0.813 | 0.6 | 0.425 |
| Onderzoek- en ontwikkelingskosten
| 3.775 | 3.775 | 3.436 | 3.436 | 2.78 | 2.78 | 4.712 | 2.356 | 3.496 | 1.748 | 1.56 | 0.78 | 1.121 | 1.121 | 0.388 | 0.784 | 1.879 | 1.879 | 0.376 | 0.443 |
| Algemene en administratieve kosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.449 | 1.449 | 0 | 0 | 0.131 | 0.131 | 1.931 | 0.523 | 0.246 | 0.246 | 0.18 | 0.136 |
| Verkoop- en marketingkosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.201 | -0.803 | 0 | 0 | -0.001 | -0.001 | 0 | 0 | 0.001 | 0.001 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 1.528 | 1.528 | 1.245 | 1.245 | 1.122 | 1.122 | 1.274 | 0.637 | 1.248 | 0.646 | 1.608 | 0.804 | 0.13 | 0.13 | 1.931 | 0.523 | 0.246 | 0.246 | 0.18 | 0.136 |
| Overige kosten
| 0.647 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.02 | 0 | 0 | 0 | -0.072 | 0 |
| Bedrijfskosten
| 5.95 | 6.052 | 4.107 | 4.107 | 4.098 | 4.098 | 5.986 | 2.915 | 4.744 | 2.499 | 3.168 | 4.374 | 1.593 | 1.593 | 2.299 | 1.307 | 2.118 | 2.118 | 0.484 | 0.579 |
| Bedrijfsresultaat
| -4.447 | -4.415 | -3.508 | -3.508 | -3.345 | -3.345 | -5.014 | -2.409 | -2.595 | -4.13 | -2.372 | -1.033 | -0.722 | -0.722 | -2.369 | -1.264 | -0.523 | -0.523 | -0.463 | -0.562 |
| Bedrijfsresultaat ratio
| -2.912 | -2.891 | -6.048 | -6.048 | -4.941 | -4.941 | -4.854 | -4.664 | -1.149 | -3.658 | -2.831 | -2.464 | -15.516 | -15.516 | -124.684 | -20.063 | -65.375 | -65.375 | -13.229 | -14.05 |
| Totaal overige inkomsten en kosten netto
| 0.074 | 0.042 | 0.191 | 0.191 | -0.135 | -0.135 | -0.066 | -0.062 | -0.415 | 2.609 | -6.096 | -3.088 | -0.98 | -0.98 | 0.207 | -0.315 | -1.711 | -1.711 | -0.166 | -0.123 |
| Inkomen voor belasting
| -4.373 | -4.373 | -3.317 | -3.317 | -3.48 | -3.48 | -5.08 | -2.471 | -3.01 | -1.521 | -8.468 | -4.12 | -1.702 | -1.702 | -2.162 | -1.579 | -2.234 | -2.234 | -0.629 | -0.685 |
| Inkomen voor belasting ratio
| -2.864 | -2.864 | -5.719 | -5.719 | -5.14 | -5.14 | -4.918 | -4.784 | -1.333 | -1.347 | -10.105 | -9.833 | -36.591 | -36.591 | -113.789 | -25.063 | -279.188 | -279.188 | -17.971 | -17.125 |
| Belastingkosten
| -0.302 | 0 | -0.291 | 0 | 0.002 | 0.002 | -0.196 | 0 | 0.216 | 0.149 | -0.306 | 0 | 0 | 0 | 0.476 | 0.001 | 0.007 | 0.007 | -0.049 | 0.006 |
| Nettowinst
| -4.373 | -4.373 | -3.317 | -3.317 | -3.482 | -3.482 | -4.942 | -2.471 | -3.339 | -1.67 | -8.24 | -4.12 | -1.702 | -1.702 | -2.638 | -1.58 | -2.148 | -2.148 | -0.58 | -0.691 |
| Nettowinstmarge
| -2.864 | -2.864 | -5.719 | -5.719 | -5.143 | -5.143 | -4.784 | -4.784 | -1.479 | -1.479 | -9.833 | -9.833 | -36.591 | -36.591 | -138.842 | -25.079 | -268.438 | -268.438 | -16.571 | -17.275 |
| WPA (Winst Per Aandeel)
| -0.16 | -0.16 | -0.12 | 0 | -0.12 | -0.12 | -0.19 | -0.095 | -0.13 | -0.065 | -0.32 | -0.16 | -0.067 | -0.067 | -0.1 | -0.067 | -0.2 | -0.2 | -0.025 | -0.029 |
| Verwaterde WPA
| -0.16 | -0.16 | -0.12 | 0 | -0.12 | -0.12 | -0.19 | -0.094 | -0.13 | -0.065 | -0.32 | -0.16 | -0.066 | -0.066 | -0.1 | -0.067 | -0.2 | -0.2 | -0.025 | -0.029 |
| EBITDA
| -4.389 | -4.37 | -3.427 | -3.427 | -3.335 | -3.335 | -4.959 | -2.382 | -2.507 | -4.117 | -2.346 | -1.02 | -0.71 | -0.71 | -1.658 | -1.324 | -0.51 | -0.51 | -0.526 | -0.544 |
| EBITDA ratio
| -2.874 | -2.862 | -5.908 | -5.908 | -4.926 | -4.926 | -4.801 | -4.611 | -1.11 | -3.647 | -2.8 | -2.433 | -15.258 | -15.258 | -87.263 | -21.016 | -63.812 | -63.812 | -15.029 | -13.6 |